TGX-115 is a p110beta/p110delta-selective, PI3-K inhibitor. TGX-115 blocks p110beta-mediated Akt phosphorylation induced by lysophosphatidic acid (LPA) in L6 myotubes, reduces insulin-stimulated PI(3,4)P2 and PIP3 levels in 3T3-L1 adipocytes. TGX-115 can be used for the study of diabetes mellitus[1][2].
Molecular Weight:
336.38
Purity:
99.25
CAS Number:
[351071-62-0]
Formula:
C20H20N2O3
Target:
PI3K
Application Notes:
MCE Product type: Reference compound1
* VAT and and shipping costs not included. Errors and price changes excepted